UK regulator: People should keep getting AstraZeneca shots
British regulators say people should keep getting AstraZeneca's COVID-19 vaccine following its review of data on patients who suffered from blood clots after getting the shot
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.British regulators said Thursday that people should keep getting AstraZeneca s COVID-19 vaccine following its review of data on patients who suffered from blood clots after getting the shot.
The Medicines and Healthcare Products Regulatory Agency said there's no evidence that the vaccine causes blood clots in veins. A further review of five reports in the U.K. of a rare type of clot in the brain is continuing, but the condition, which can occur naturally, has been reported in less than 1 in a million people vaccinated so far and no causal link has been established, the agency said.
“The MHRA’s advice remains that the benefits of the vaccines against COVID-19 continue to outweigh any risks and that the public should continue to get their vaccine when invited to do so,'' the agency said.